Ruth C Carlos1, JoRean D Sicks2, Caroline Chiles3, Lucy Gansauer4, Charles S Kamen5, Anne E Kazak6, Heather B Neuman7, Joseph M Unger8, Kathryn E Weaver9. 1. Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan. Electronic address: rcarlos@med.umich.edu. 2. ECOG-ACRIN Biostatistics and Data Management Center, Brown University Center for Statistical Sciences, Providence, Rhode Island. 3. Department of Radiology, Wake Forest University Health Sciences Center, Medical Center Boulevard, Winston-Salem, North Carolina. 4. Spartanburg Medical Center, Spartanburg, South Carolina. 5. Cancer Control Unit, University of Rochester, Rochester, New York. 6. Nemours Center for Healthcare Delivery Science, Nemours Children's Health System, Wilmington, Delaware. 7. Department of Surgery, University of Wisconsin, Madison, Wisconsin. 8. SWOG Statistics and Data Management Center, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. 9. Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina.
Abstract
PURPOSE: Annual low-dose CT (LDCT) for lung screening in high-risk individuals decreases both lung cancer-specific mortality and all-cause mortality. Community oncology practice networks constituting the National Cancer Institute Community Oncology Research Program (NCORP) conduct clinical trials across the cancer spectrum. The authors report access to and characteristics of LDCT screening for lung cancer in these community oncology practices. METHODS: A landscape capacity assessment was conducted in 2017 across the NCORP network. The primary outcome was the proportion of adult oncology practice groups offering LDCT lung screening on site. The secondary outcomes were the proportion of those screening services (1) with radiologist participation in service management and (2) offered at ACR Designated Lung Cancer Screening Centers. RESULTS: Fifty-two percent of components and subcomponents responded to at least some portion of the assessment, representing 217 practice groups. Analyzing the 211 adult oncology practice groups responding to the primary question, 73% offered lung screening services on site. Radiologists participated in managing 69% of these services. Forty-seven percent were offered in ACR Designated Lung Cancer Screening Centers. Minority and underserved practice groups were less likely to offer lung screening; however, this association dissipated when analyses focused on practices within the United States. Safety net and Critical Access Hospital designation increased the likelihood of screening availability. CONCLUSIONS: The majority of community oncology practice groups within the NCORP offered lung screening on site, although radiologist participation in service management and ACR Lung Cancer Screening Center designation, markers of service quality, were more variable.
PURPOSE: Annual low-dose CT (LDCT) for lung screening in high-risk individuals decreases both lung cancer-specific mortality and all-cause mortality. Community oncology practice networks constituting the National Cancer Institute Community Oncology Research Program (NCORP) conduct clinical trials across the cancer spectrum. The authors report access to and characteristics of LDCT screening for lung cancer in these community oncology practices. METHODS: A landscape capacity assessment was conducted in 2017 across the NCORP network. The primary outcome was the proportion of adult oncology practice groups offering LDCT lung screening on site. The secondary outcomes were the proportion of those screening services (1) with radiologist participation in service management and (2) offered at ACR Designated Lung Cancer Screening Centers. RESULTS: Fifty-two percent of components and subcomponents responded to at least some portion of the assessment, representing 217 practice groups. Analyzing the 211 adult oncology practice groups responding to the primary question, 73% offered lung screening services on site. Radiologists participated in managing 69% of these services. Forty-seven percent were offered in ACR Designated Lung Cancer Screening Centers. Minority and underserved practice groups were less likely to offer lung screening; however, this association dissipated when analyses focused on practices within the United States. Safety net and Critical Access Hospital designation increased the likelihood of screening availability. CONCLUSIONS: The majority of community oncology practice groups within the NCORP offered lung screening on site, although radiologist participation in service management and ACRLung Cancer Screening Center designation, markers of service quality, were more variable.
Authors: Marc N Elliott; Amelia M Haviland; Jacob W Dembosky; Katrin Hambarsoomian; Robert Weech-Maldonado Journal: Med Care Date: 2012-03 Impact factor: 2.983
Authors: Denise R Aberle; Christine D Berg; William C Black; Timothy R Church; Richard M Fagerstrom; Barbara Galen; Ilana F Gareen; Constantine Gatsonis; Jonathan Goldin; John K Gohagan; Bruce Hillman; Carl Jaffe; Barnett S Kramer; David Lynch; Pamela M Marcus; Mitchell Schnall; Daniel C Sullivan; Dorothy Sullivan; Carl J Zylak Journal: Radiology Date: 2010-11-02 Impact factor: 11.105
Authors: Jan M Eberth; Rebecca Qiu; Swann A Adams; Ramzi G Salloum; Nathanial Bell; Amanda K Arrington; Suzanne K Linder; Reginald F Munden Journal: Lung Cancer Date: 2014-07-21 Impact factor: 5.705
Authors: Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks Journal: N Engl J Med Date: 2011-06-29 Impact factor: 91.245
Authors: Christina Bellinger; Kristie Long Foley; Emily V Dressler; Carol Kittel; David P Miller; Kathryn E Weaver; Erin L Sutfin; W Jeffrey Petty; John Spangler; Rebecca Stone; Daniel M Anderson; Heather Kehn; Cindy Steenstra; Rajiv Panikkar; Caroline Chiles Journal: J Am Coll Radiol Date: 2022-03-02 Impact factor: 5.532
Authors: Talya Salz; Jamie S Ostroff; Chandylen L Nightingale; Thomas M Atkinson; Eleanor C Davidson; Sankeerth R Jinna; Anuja Kriplani; Glenn J Lesser; Kathleen A Lynch; Deborah K Mayer; Kevin C Oeffinger; Sujata Patil; Andrew L Salner; Kathryn E Weaver Journal: Contemp Clin Trials Date: 2021-05-21 Impact factor: 2.261